ASX:GLH Tag

Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 30 June 2026, and the accompanying Quarterly Business Activity Report. The financial performance commentary for the June-2026 quarter is relative to...

Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 31 March 2026 (Q3 FY26), and the accompanying Quarterly Business Activity Report. The financial performance commentary for the Mar-26 quarter is...

Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 30 June 2025, and the accompanying Quarterly Business Activity Report. The financial performance commentary for the June-2025 quarter is relative to...

Global Health Limited (ASX: GLH) (“Global Health” or “the Group”) is pleased to release its Appendix 4C Cash Flow Report for the quarter ended 31 March 2025 (Q3 FY25), and the accompanying Quarterly Business Activity Report. The financial performance commentary for the Mar-25 quarter is...

Result highlights include: Annual Recurring Revenue up 13% on PCP Cash receipts up 13% on the Previous Corresponding Period (PCP) Net Operating and Investing cashflow reduced by 14% from PCP Group Cashflow deficit reduced by 28% from PCP Global Health Limited (ASX: GLH) (“Global Health” or...